📰 Statistical Analysis Plan News
Statistical Analysis Plan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statistical Analysis Plan. Real-time updates on events, politics, business and more.
May 19, 2024
This randomized trial assesses whether acetaminophen would increase the number of days alive and free of organ support to day 28 among critically ill
February 15, 2024
Alnylam's change to a key clinical trial design appears to have worried investors more than a small Q4 revenue miss.
December 28, 2023
Julia van der Meulen and co-workers compare procedural sedation and analgesia versus general anesthesia in women undergoing hysteroscopic myomectomy for fibroids.
November 30, 2023
BioVie Inc (NASDAQ:BIVI), the clinical-stage company specializing in drug therapies for neurological disorders, revealed new results from the Phase 3 trial...
November 29, 2023
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker...
November 29, 2023
29.11.2023 - Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker Endpoints Sponsor Identified Issues Relating to Significant GCP Violations and Protocol ...
September 28, 2023
BioVie Inc (NASDAQ:BIVI) said the last patient has completed their final visit at week 30 in their Phase 3 study of investigational therapy NE3107 in...
April 6, 2023
Operator: Good afternoon and welcome to the NRx Pharmaceuticals Full Year 2022 Results Conference Call. All participants will be in a listen-only mode.
March 30, 2023
Over the past 12 months, the Company reinitiated its psychiatry development program post pandemic, transferred manufacturing of NRX-101 to the US, and...
January 31, 2023
In a randomized controlled trial, Adrian Wells and colleagues test the effectiveness of adding self-help metacognitive therapy to cardiac rehabilitation in reducing anxiety and depression.